Company intelligence
Forbion
Impacting the future
About Forbion
Forbion is a leading global venture capital firm with deep expertise in Europe. We invest in innovative biotech companies, managing just over €5 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In addition, we leverage our biotech expertise beyond human health to address ‘planetary health’ challenges through our BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies.
Verified activity
Signals from Forbion
14 published signals
Products & Services
Forbion portfolio company AAVantgarde completed enrolment of 15 participants in the Phase 1/2 LUCE-1 study for Usher syndrome type 1B and received FDA clearance to advance AAVB-039 into the CELESTE study for Stargardt disease.
Reported by Forbion
Partnerships
Forbion portfolio company AAVantgarde became the first company to evaluate a dual-AAV gene therapy clinically in the retina.
Reported by Forbion
Presence & Recognition
Forbion and BGV participated in the Amsterdam City Swim event supporting the fight against ALS, raising over €8,500.
Reported by Forbion
Presence & Recognition
Forbion is hosting the IPEM Global Paris event in Paris, France from September 8 to 10.
Reported by Forbion
Presence & Recognition
Forbion is hosting the Grand Rounds: Europe 2026 event at BioCentury Inc. in Amsterdam, Netherlands from September 23 to 25.
Reported by Forbion
Presence & Recognition
Forbion is hosting the European Respiratory Society (ERS) Congress 2026 in Barcelona, Spain from September 5 to 9.
Reported by Forbion
Presence & Recognition
Forbion is hosting the Climate Week NYC 2026 event in New York, USA from September 20 to 27.
Reported by Forbion
Presence & Recognition
Forbion is hosting the ABI Sweden 2026 event in Stockholm, Sweden from September 24 to 25.
Reported by Forbion
Presence & Recognition
Forbion is hosting the 2026 Society for Immunotherapy of Cancer (SITC) EU Immuno-Oncology Drug Development Summit in Lausanne, Switzerland from September 3 to 4.
Reported by Forbion
Presence & Recognition
Forbion is hosting the Nordic Life Science Days 2026 event in Stockholm, Sweden from September 8 to 9.
Reported by Forbion
Presence & Recognition
Forbion is hosting the Morgan Stanley 24th Annual Global Healthcare Conference in New York, USA from September 14 to 16.
Reported by Forbion
Presence & Recognition
Forbion is hosting the Life Science Investors' Day 2026 event at Technologiepark Heidelberg GmbH in Heidelberg, Germany from September 24.
Reported by Forbion
Presence & Recognition
Forbion is hosting the The Drop 2026 event in Malmö, Sweden from September 15 to 16.
Reported by Forbion
People
Forbion welcomed six new colleagues to the team, including Thijs Verburg as Partner, Investor Relations, G. Kees Hovingh as Venture Partner, Meike Logtenberg as Principal, Arjan Oosterheert as Head of Tax, Thijs van Egmond as Legal Counsel, and Britt Inga Emerson as Senior Executive Assistant, Investor Relations.
Reported by Forbion